Limitations, agreements, and source contact

Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia · Source last updated 2017-12-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

restrictive Agreement

false

limitations And Caveats

description

Study was terminated early due to lack of NK expansion and failure to meet primary outcome.

point Of Contact

email

bach0173@umn.edu

organization

Masonic Cancer Center, University of Minnesota

phone

612-625-5469

title

Veronika Bachanova, M.D.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice